Joseph G. Skeate

Tackling anti-tumor macrophage function through genome engineering

In the realm of cellular immunotherapies, the synthetic chimeric antigen receptor (CAR) has proven to be a revolutionary modality, leading to the US Food and Drug Administration approval of multiple autologous CAR T cell products. Despite their remarkable success in hematological...